Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
13.27
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
13.31
+0.04 (0.30%)
After-hours: Dec 5, 2025, 5:27 PM EST
Pulse Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -74.73 | -53.59 | -42.21 | -58.51 | -63.66 | -49.85 | |
| Depreciation & Amortization | 1.1 | 1.18 | 1.21 | 1.36 | 1.15 | 1.1 | |
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 0.01 | 0.19 | - | 0.12 | |
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.01 | -0 | |
| Stock-Based Compensation | 23.28 | 13.59 | 7.18 | 5.19 | 14.6 | 10.08 | |
| Other Operating Activities | - | - | - | 8.48 | - | - | |
| Change in Accounts Receivable | -0.02 | - | - | 0.06 | -0.06 | - | |
| Change in Inventory | -0.06 | - | - | -2.65 | -5.82 | - | |
| Change in Accounts Payable | 1.31 | -0.2 | 0.26 | -1.3 | 1.16 | -0.27 | |
| Change in Unearned Revenue | - | - | - | -0.02 | 0.02 | - | |
| Change in Other Net Operating Assets | 0.6 | 2.67 | 0.51 | 0.2 | -1.49 | 3.47 | |
| Operating Cash Flow | -48.51 | -36.34 | -33.04 | -47.01 | -54.1 | -35.37 | |
| Capital Expenditures | -0.26 | -0.13 | -0.12 | -0.4 | -0.44 | -0.44 | |
| Investment in Securities | - | - | - | - | 8 | 10.49 | |
| Investing Cash Flow | -0.28 | -0.13 | -0.12 | -0.4 | 7.56 | 10.04 | |
| Short-Term Debt Issued | - | - | - | - | 1.94 | - | |
| Long-Term Debt Issued | - | - | - | 65 | - | - | |
| Total Debt Issued | - | - | - | 65 | 1.94 | - | |
| Short-Term Debt Repaid | - | - | - | -0.44 | -1.53 | - | |
| Total Debt Repaid | - | - | - | -0.44 | -1.53 | - | |
| Net Debt Issued (Repaid) | - | - | - | 64.56 | 0.41 | - | |
| Issuance of Common Stock | 65.03 | 110.42 | 16.39 | 15.38 | 62.51 | 30.89 | |
| Repurchase of Common Stock | - | - | - | - | -0.23 | - | |
| Other Financing Activities | -0.06 | -0.28 | -0.01 | - | - | - | |
| Financing Cash Flow | 64.98 | 110.14 | 16.39 | 79.94 | 62.69 | 30.89 | |
| Net Cash Flow | 16.18 | 73.67 | -16.77 | 32.53 | 16.15 | 5.56 | |
| Free Cash Flow | -48.77 | -36.47 | -33.16 | -47.41 | -54.53 | -35.81 | |
| Free Cash Flow Margin | -56713.95% | - | - | -6773.43% | -3845.84% | - | |
| Free Cash Flow Per Share | -0.74 | -0.62 | -0.67 | -1.40 | -1.95 | -1.54 | |
| Cash Interest Paid | - | - | 1.7 | - | - | - | |
| Levered Free Cash Flow | -23.17 | -17.92 | -18.13 | -26.84 | -30.4 | -18.77 | |
| Unlevered Free Cash Flow | -23.17 | -17.92 | -17.44 | -26.27 | -29.96 | -18.77 | |
| Change in Working Capital | 1.84 | 2.47 | 0.77 | -3.72 | -6.2 | 3.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.